Dr. Chung is a distinguished cancer researcher with a prolific publication record of over 220 scientific articles. His expertise lies in advanced genetic and proteomic analyses, with a primary focus on tissue-based biomarkers for cancer diagnosis, prognosis, and therapy response. Additionally, his work extends to the development of novel radiopharmaceutical agents for cancer imaging and treatment, particularly in gastrointestinal and gynecologic cancers. Dr. Chung is highly skilled in generating isogenic cell lines using the lentivirus system, gene editing via the CRISPR/Cas9 system, histology, immunohistochemistry, digital image analysis, and animal cancer models.